EPH receptor A2

EPHA2
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesEPHA2, Epha2, AW545284, Eck, Myk2, Sek-2, Sek2, ARCC2, CTPA, CTPP1, CTRCT6, EPH receptor A2, ECK
External IDsMGI: 95278 HomoloGene: 20929 GeneCards: EPHA2
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

1969

13836

Ensembl

ENSG00000142627

ENSMUSG00000006445

UniProt

P29317

Q03145

RefSeq (mRNA)

NM_004431
NM_001329090

NM_010139

RefSeq (protein)

NP_001316019
NP_004422

NP_034269

Location (UCSC)Chr 1: 16.12 – 16.16 MbChr 4: 141.3 – 141.33 Mb
PubMed search[1][2]
Wikidata
View/Edit HumanView/Edit Mouse

EPH receptor A2 (ephrin type-A receptor 2) is a protein that in humans is encoded by the EPHA2 gene.[3][4]

Function

This gene belongs to the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. This gene encodes a protein that binds ephrin-A ligands.[4]

Clinical significance

It may be implicated in BRAF mutated melanomas becoming resistant to BRAF-inhibitors and MEK inhibitors.[5] It also the receptor by which Kaposi sarcoma-associated herpesvirus (KSHV) enters host cells and small molecule inhibitors of EphA2 have shown some ability to block KSHV entry into human cells.[6]

Interactions

EPH receptor A2 has been shown to interact with:

References

  1. "Human PubMed Reference:".
  2. "Mouse PubMed Reference:".
  3. Sulman EP, Tang XX, Allen C, Biegel JA, Pleasure DE, Brodeur GM, Ikegaki N (April 1997). "ECK, a human EPH-related gene, maps to 1p36.1, a common region of alteration in human cancers". Genomics. 40 (2): 371–4. PMID 9119409. doi:10.1006/geno.1996.4569.
  4. 1 2 "Entrez Gene: EPHA2 EPH receptor A2".
  5. "Counteracting Drug Resistance in Melanoma". 2015.
  6. Hahn AS, Kaufmann JK, Wies E, Naschberger E, Panteleev-Ivlev J, Schmidt K, Holzer A, Schmidt M, Chen J, König S, Ensser A, Myoung J, Brockmeyer NH, Stürzl M, Fleckenstein B, Neipel F (2012). "The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus". Nat. Med. 18 (6): 961–6. PMC 3645317Freely accessible. PMID 22635007. doi:10.1038/nm.2805.
  7. Kikawa KD, Vidale DR, Van Etten RL, Kinch MS (October 2002). "Regulation of the EphA2 kinase by the low molecular weight tyrosine phosphatase induces transformation". J. Biol. Chem. 277 (42): 39274–9. PMID 12167657. doi:10.1074/jbc.M207127200.
  8. 1 2 Pratt RL, Kinch MS (October 2002). "Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade". Oncogene. 21 (50): 7690–9. PMID 12400011. doi:10.1038/sj.onc.1205758.
  9. Pandey A, Lazar DF, Saltiel AR, Dixit VM (December 1994). "Activation of the Eck receptor protein tyrosine kinase stimulates phosphatidylinositol 3-kinase activity". J. Biol. Chem. 269 (48): 30154–7. PMID 7982920.

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.